Molecular mechanisms of Angelica sinensis (Oliv.) Diels in women's health
当归对女性健康的分子机制
基本信息
- 批准号:7812964
- 负责人:
- 金额:$ 14.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-aminobutyric acidAddressAdenylate CyclaseAdverse effectsAffectAffinityAgonistAmericanAmerican Psychiatric AssociationAngelica sinensisAngelica sinensis preparationAnxietyAttenuatedBindingBiological AssayBody TemperatureBotanicalsCell LineCellsChinaClinical ResearchCyclic AMPDataDiseaseDopamine ReceptorDoseDrug usageEffectivenessEnsureExhibitsExpenditureFemaleFutureGABA-A ReceptorGTP-Binding ProteinsHealthHerbHormonalHot flushesHyperalgesiaInhibitory Concentration 50KnowledgeLigandsMeasuresMedicalMenopausal SymptomMenopauseMethodsModelingMolecularMolecular Mechanisms of ActionMood DisordersNeurotransmittersNorepinephrineOccupationsOpiatesOpioid ReceptorPharmaceutical PreparationsPharmacologic SubstancePhysiologicalPlant RootsPlantsPopulationPremenstrual syndromeRattusReceptor ActivationResearchResearch ActivityRodentSerotoninSiteSleeplessnessSymptomsSynaptosomesSystemTestingTimeUnited StatesWomanWomen&aposs HealthWorkbasedepressiondietary supplementsgamma-Aminobutyric Acidhigh throughput screeningin vivomonoaminemood regulationpremenstrual dysphoric disorderprotein activationpublic health relevancereceptorreceptor bindingresearch study
项目摘要
DESCRIPTION (provided by applicant): A large segment of the female population is affected by premenstrual syndrome (PMS) and menopausal symptoms. Limited medical treatments are available, some with severe adverse effects. Instead, many women have turned to botanical dietary supplements. Angelica sinensis (Oliv.) Diels is one of the most commonly used botanical dietary supplements for the relief of PMS and menopausal symptoms. Although the dried root of thi plant, also known as Dong quai, has been used traditionally in China for centuries and is currently being used by many American women, its mechanisms of action are poorly understood. We hypothesize that Angelica sinensis can act through CNS receptors to exhibit beneficial effects in PMS and menopause. In the original application, we propose to test this hypothesis by first evaluating the affinity of several chemically characterized Angelica sinensis extracts to the opiate and 3-aminobutyric acid (GABA)-A receptors. The extracts will be further tested for their activation of opiate receptors by measuring G protein activation and adenylyl cyclase inhibition and the activation of the GABA(A) receptor by determining GABA-gated Cl- influx in synaptosomes. Aim 3 will determine the in vivo efficacy of two extracts in a rat model. In the revised application, we propose to expand the scope of research to include other relevant CNS receptor and transporter systems. Accordingly, the new aim 4 will examine the affinity of these extracts to the monoamine receptors and transporters. The additional studies will accelerate the tempo of scientific research and allow for job creation. Results from these studies will help to define the molecular mechanisms of action of Angelica sinensis. Such information will not only provide mechanistic evidence for the use of Angelica sinensis in relieving PMS and menopausal symptoms, but may also be used to biologically standardize an Angelica sinensis product for future clinical studies.
PUBLIC HEALTH RELEVANCE: A large segment of the female population is affected by premenstrual syndrome (PMS) and menopausal symptoms. Although Angelica sinensis (Oliv.) Diels is one of the most commonly used botanical dietary supplements for the relief of PMS and menopausal symptoms, little is known for its mechanisms. This application aims to apply molecular methods to study mechanisms of action of Angelica sinensis. The competitive revision will expand the scope of research to address the possible mechanisms of action through the monoamine receptors and transporters for Angelica sinensis. In addition to the new knowledge to be gained, the revised aims will accelerate the tempo of scientific research and allow for job creation through direct hiring of additional staff and indirect impact due to increased research activity and expenditure.
描述(由申请人提供):大部分女性受经前综合征(PMS)和更年期症状的影响。可用的医疗手段有限,有些有严重的副作用。相反,许多女性已经转向植物性膳食补充剂。当归(当归)Diels是最常用的植物膳食补充剂之一,用于缓解PMS和更年期症状。虽然这种植物的干根,也被称为当归,在中国传统上使用了几个世纪,目前被许多美国妇女使用,但人们对其作用机制知之甚少。我们推测当归可以通过中枢神经系统受体发挥作用,在PMS和更年期表现出有益的效果。在最初的申请中,我们建议通过首先评估几种化学特征的当归提取物对阿片和3-氨基丁酸(GABA)-A受体的亲和力来测试这一假设。将通过测量G蛋白活化和腺苷酸环化酶抑制进一步测试提取物对阿片受体的活化,并通过测定突触体中GABA门控Cl-内流来测试GABA(A)受体的活化。目的3将确定两种浸提液在大鼠模型中的体内有效性。在修订后的申请中,我们建议扩大研究范围,以包括其他相关的中枢神经系统受体和转运系统。因此,新的目的4将检查这些提取物对单胺受体和转运蛋白的亲和力。这些额外的研究将加快科学研究的克里思,并创造就业机会。这些研究结果将有助于确定当归作用的分子机制。这些信息不仅为当归在缓解PMS和更年期症状中的应用提供了机制证据,而且还可用于生物标准化当归产品以用于未来的临床研究。
公共卫生相关性:很大一部分女性人口受到经前综合征(PMS)和更年期症状的影响。当归Angelica sinensis(Oliv.)Diels是最常用的植物膳食补充剂之一,用于缓解PMS和更年期症状,其机制知之甚少。本申请旨在应用分子生物学方法研究当归的作用机制。竞争性修订将扩大研究范围,以解决当归通过单胺受体和转运蛋白的可能作用机制。除了获得新知识外,修订后的目标还将加快科学研究的克里思,并通过直接雇用额外的工作人员和增加研究活动和支出产生的间接影响创造就业机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zaijie Jim Wang其他文献
Inhibition of CaMKIIa in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
杏仁核中央核 CaMKIIa 的抑制可减轻芬太尼引起的大鼠痛觉过敏
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Chenhong Li;Pingping Yin;Zaijie Jim Wang;Fang Luo - 通讯作者:
Fang Luo
Β-Lactam Antibiotic Ceftriaxone As a Potential Therapeutic Intervention for Chronic Pain in Sickle Cell Disease
- DOI:
10.1182/blood-2023-188342 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Ying He;Xiao Guo;Robert Molokie;Zaijie Jim Wang - 通讯作者:
Zaijie Jim Wang
Zaijie Jim Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zaijie Jim Wang', 18)}}的其他基金
Molecular mechanism and targeting of chronic pain in sickle cell disease
镰状细胞病慢性疼痛的分子机制和靶向
- 批准号:
10538592 - 财政年份:2018
- 资助金额:
$ 14.56万 - 项目类别:
Molecular mechanism and targeting of chronic pain in sickle cell disease
镰状细胞病慢性疼痛的分子机制和靶向
- 批准号:
10319980 - 财政年份:2018
- 资助金额:
$ 14.56万 - 项目类别:
Molecular mechanism and targeting of chronic pain in sickle cell disease
镰状细胞病慢性疼痛的分子机制和靶向
- 批准号:
10078630 - 财政年份:2018
- 资助金额:
$ 14.56万 - 项目类别:
Molecular mechanisms of Angelica sinensis (Oliv.) Diels in women's health
当归对女性健康的分子机制
- 批准号:
7759628 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
Protein kinase mechanisms for chronic pain in sickle cell disease
镰状细胞病慢性疼痛的蛋白激酶机制
- 批准号:
9127679 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
Molecular mechanisms of Angelica sinensis (Oliv.) Diels in women?s health
当归对女性健康的分子机制
- 批准号:
7600284 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
CaMKII as a Mechanism & Intervention Target for Sickle Cell Pain
CaMKII 作为一种机制
- 批准号:
7765396 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
CaMKII as a Mechanism & Intervention Target for Sickle Cell Pain
CaMKII 作为一种机制
- 批准号:
8135268 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
CaMKII as a Mechanism & Intervention Target for Sickle Cell Pain
CaMKII 作为一种机制
- 批准号:
8322679 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
Protein kinase mechanisms for chronic pain in sickle cell disease
镰状细胞病慢性疼痛的蛋白激酶机制
- 批准号:
9242067 - 财政年份:2009
- 资助金额:
$ 14.56万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 14.56万 - 项目类别:
Research Grant